Clinical trial
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in…
NCT00081484 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00081484 |
|---|---|
| Title | A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients |
| Official title | A Randomized, Open-label Study of the Effect of Maintenance Mircera Administered With Pre-filled Syringes on Hemoglobin Levels in Anemic Dialysis Patients With Chronic Kidney Disease |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | epoetin alfa or beta, methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 336 |
| Start date | Jun 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Apr 16, 2004 |
| Last update posted | Nov 2, 2016 |
| Countries | Canada, France, Germany, Italy, Poland, Portugal, Puerto Rico, Spain, Taiwan, Thailand, United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: